Analyst Ratings for Karyopharm Therapeutics (KPTI)
KPTI Rating Summary
KPTI Price Target Summary
- Highest: $10.00 (H.C. Wainwright)
- Lowest: $3.00 (RBC Capital)
- Average: $5.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.67 (+260.9%)
* Over Last 12-Mos
Rating Score: 7.1 / 10 Percentile Rank: 77%
Rating Score: 7.1 / 10 Percentile Rank: 77%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/19/2023 | Piper Sandler » Updated 11/2/2023 |
Christopher Reynolds | New Coverage | Overweight (N/A) |
5.00 (7.00) |
3.11 (1.57) |
-49.52% | Details |
11/4/2022 | RBC Capital » Updated 11/3/2023 |
Brian Abrahams | Upgrade | Outperform (Sector Perform) |
3.00 (4.00) |
4.54 (1.57) |
-65.42% | Details |